Cargando…

Vasculitis changes in COVID-19 survivors with persistent symptoms: an [(18)F]FDG-PET/CT study

PURPOSE: Several patients experience unexplained persistent symptoms after SARS-CoV-2 recovering. We aimed at evaluating if 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG) was able to demonstrate a persistent inflammatory process. METHODS: Recovered adult COVID-19 patients, who complained unexplained...

Descripción completa

Detalles Bibliográficos
Autores principales: Sollini, Martina, Ciccarelli, Michele, Cecconi, Maurizio, Aghemo, Alessio, Morelli, Paola, Gelardi, Fabrizia, Chiti, Arturo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595761/
https://www.ncbi.nlm.nih.gov/pubmed/33123760
http://dx.doi.org/10.1007/s00259-020-05084-3
_version_ 1783601947967750144
author Sollini, Martina
Ciccarelli, Michele
Cecconi, Maurizio
Aghemo, Alessio
Morelli, Paola
Gelardi, Fabrizia
Chiti, Arturo
author_facet Sollini, Martina
Ciccarelli, Michele
Cecconi, Maurizio
Aghemo, Alessio
Morelli, Paola
Gelardi, Fabrizia
Chiti, Arturo
author_sort Sollini, Martina
collection PubMed
description PURPOSE: Several patients experience unexplained persistent symptoms after SARS-CoV-2 recovering. We aimed at evaluating if 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG) was able to demonstrate a persistent inflammatory process. METHODS: Recovered adult COVID-19 patients, who complained unexplained persisting symptoms for more than 30 days during the follow-up visits, were invited to participate in the study. Patients fulfilling inclusion criteria were imaged by [(18)F]FDG positron emission tomography/computed tomography ([(18)F]FDG-PET/CT). Whole-body [(18)F]FDG-PET/CT, performed according to good clinical practice, was qualitatively (comparison with background/liver) and semi-quantitatively (target-to-blood pool ratio calculated as average SUVmax artery/average SUVmean inferior vena cava) analyzed. Negative follow-up [(18)F]FDG-PET/CT images of oncologic patients matched for age/sex served as controls. Mann-Whitney test was used to test differences between groups. SPSS version 26 was used for analyses. RESULTS: Ten recovered SARS-CoV-2 patients (seven male and three females, median age 52 years, range 46–80) with persisting symptoms were enrolled in the study. Common findings at visual analysis were increased [(18)F]FDG uptake in bone marrow and blood vessels (8/10 and 6/10 cases, respectively). [(18)F]FDG uptake in bone marrow did not differ between cases and controls (p = 0.16). The total vascular score was similar in the two groups (p = 0.95). The target-to-blood pool ratio resulted higher in recovered SARS-CoV-2 patients than in controls. CONCLUSION: Although the total vascular score was similar in the two groups, the target-to-blood pool ratio was significantly higher in three vascular regions (thoracic aorta, right iliac artery, and femoral arteries) in the recovered COVID-19 cohort than in controls, suggesting that SARS-CoV-2 induces vascular inflammation, which may be responsible for persisting symptoms.
format Online
Article
Text
id pubmed-7595761
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-75957612020-10-30 Vasculitis changes in COVID-19 survivors with persistent symptoms: an [(18)F]FDG-PET/CT study Sollini, Martina Ciccarelli, Michele Cecconi, Maurizio Aghemo, Alessio Morelli, Paola Gelardi, Fabrizia Chiti, Arturo Eur J Nucl Med Mol Imaging Short Communication PURPOSE: Several patients experience unexplained persistent symptoms after SARS-CoV-2 recovering. We aimed at evaluating if 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG) was able to demonstrate a persistent inflammatory process. METHODS: Recovered adult COVID-19 patients, who complained unexplained persisting symptoms for more than 30 days during the follow-up visits, were invited to participate in the study. Patients fulfilling inclusion criteria were imaged by [(18)F]FDG positron emission tomography/computed tomography ([(18)F]FDG-PET/CT). Whole-body [(18)F]FDG-PET/CT, performed according to good clinical practice, was qualitatively (comparison with background/liver) and semi-quantitatively (target-to-blood pool ratio calculated as average SUVmax artery/average SUVmean inferior vena cava) analyzed. Negative follow-up [(18)F]FDG-PET/CT images of oncologic patients matched for age/sex served as controls. Mann-Whitney test was used to test differences between groups. SPSS version 26 was used for analyses. RESULTS: Ten recovered SARS-CoV-2 patients (seven male and three females, median age 52 years, range 46–80) with persisting symptoms were enrolled in the study. Common findings at visual analysis were increased [(18)F]FDG uptake in bone marrow and blood vessels (8/10 and 6/10 cases, respectively). [(18)F]FDG uptake in bone marrow did not differ between cases and controls (p = 0.16). The total vascular score was similar in the two groups (p = 0.95). The target-to-blood pool ratio resulted higher in recovered SARS-CoV-2 patients than in controls. CONCLUSION: Although the total vascular score was similar in the two groups, the target-to-blood pool ratio was significantly higher in three vascular regions (thoracic aorta, right iliac artery, and femoral arteries) in the recovered COVID-19 cohort than in controls, suggesting that SARS-CoV-2 induces vascular inflammation, which may be responsible for persisting symptoms. Springer Berlin Heidelberg 2020-10-30 2021 /pmc/articles/PMC7595761/ /pubmed/33123760 http://dx.doi.org/10.1007/s00259-020-05084-3 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Short Communication
Sollini, Martina
Ciccarelli, Michele
Cecconi, Maurizio
Aghemo, Alessio
Morelli, Paola
Gelardi, Fabrizia
Chiti, Arturo
Vasculitis changes in COVID-19 survivors with persistent symptoms: an [(18)F]FDG-PET/CT study
title Vasculitis changes in COVID-19 survivors with persistent symptoms: an [(18)F]FDG-PET/CT study
title_full Vasculitis changes in COVID-19 survivors with persistent symptoms: an [(18)F]FDG-PET/CT study
title_fullStr Vasculitis changes in COVID-19 survivors with persistent symptoms: an [(18)F]FDG-PET/CT study
title_full_unstemmed Vasculitis changes in COVID-19 survivors with persistent symptoms: an [(18)F]FDG-PET/CT study
title_short Vasculitis changes in COVID-19 survivors with persistent symptoms: an [(18)F]FDG-PET/CT study
title_sort vasculitis changes in covid-19 survivors with persistent symptoms: an [(18)f]fdg-pet/ct study
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595761/
https://www.ncbi.nlm.nih.gov/pubmed/33123760
http://dx.doi.org/10.1007/s00259-020-05084-3
work_keys_str_mv AT sollinimartina vasculitischangesincovid19survivorswithpersistentsymptomsan18ffdgpetctstudy
AT ciccarellimichele vasculitischangesincovid19survivorswithpersistentsymptomsan18ffdgpetctstudy
AT cecconimaurizio vasculitischangesincovid19survivorswithpersistentsymptomsan18ffdgpetctstudy
AT aghemoalessio vasculitischangesincovid19survivorswithpersistentsymptomsan18ffdgpetctstudy
AT morellipaola vasculitischangesincovid19survivorswithpersistentsymptomsan18ffdgpetctstudy
AT gelardifabrizia vasculitischangesincovid19survivorswithpersistentsymptomsan18ffdgpetctstudy
AT chitiarturo vasculitischangesincovid19survivorswithpersistentsymptomsan18ffdgpetctstudy